Solid Q4 caps of difficult FY25; Chg.

NFON's FY25 prelim figures exceed expectations, with stable sales and EBITDA. Management targets modest FY26 growth. Reiterate BUY with a new PT of €8.70, reflecting an attractive risk/reward profile.